Minerva Neurosciences (NERV) Non-Current Deffered Revenue (2017 - 2020)

Minerva Neurosciences (NERV) has 4 years of Non-Current Deffered Revenue data on file, last reported at $41.2 million in Q1 2020.

• For the quarter ending Q1 2020, Non-Current Deffered Revenue changed 0.0% year-over-year to $41.2 million; the trailing twelve-month figure through Mar 2020 stood at $41.2 million (changed 0.0% YoY), and the FY2019 full-year result was $41.2 million, changed 0.0% from the prior year.
• Non-Current Deffered Revenue for Q1 2020 stood at $41.2 million, roughly flat from $41.2 million in the prior quarter.
• Across five years, Non-Current Deffered Revenue topped out at $41.2 million in Q3 2017 and bottomed at $41.2 million in Q3 2017.
• The 4-year median for Non-Current Deffered Revenue is $41.2 million (2017), against an average of $41.2 million.
• Peak annual rise in Non-Current Deffered Revenue reached 0.0% in 2018, while the deepest fall reached 0.0% in 2018.
• A 4-year view of Non-Current Deffered Revenue shows it stood at $41.2 million in 2017, then changed by 0.0% to $41.2 million in 2018, then changed by 0.0% to $41.2 million in 2019, then changed by 0.0% to $41.2 million in 2020.
• The last three Non-Current Deffered Revenue figures came in at $41.2 million (Q1 2020), $41.2 million (Q4 2019), and $41.2 million (Q3 2019), per Business Quant data.

Peer Comparison